Jacek Biesiada

Jacek Biesiada

Auto-generated profile, based on publicly available information

Jacek Biesiada

Division of Biostatistics and Bioinformatics, Department of Environmental and Public Health Sciences University of Cincinnati College of Medicine

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2012 in Cancer Cell
Verified
Journal Article
Closed access
OMOlga Mikhaylova
Olga Mikhaylova
YSYiwen Stratton
Yiwen Stratton
DHDaniel Hall
Daniel Hall
EKEmily Kellner
Emily Kellner
BEBirgit Ehmer
Birgit Ehmer
Maria F. Czyzyk-KrzeskaMaria F. Czyzyk-Krzeska
Maria F. Czyzyk-Krzeska

1 November 2014 in Cancer Cell
Verified
Journal Article
Closed access
DHDaniel P. Hall
Daniel P. Hall
NCNicholas G. Cost
Nicholas G. Cost
SHShailaja Hegde
Shailaja Hegde
EKEmily Kellner
Emily Kellner
OMOlga Mikhaylova
Olga Mikhaylova
Maria F. Czyzyk-KrzeskaMaria F. Czyzyk-Krzeska
Maria F. Czyzyk-Krzeska

15 September 2012 in Journal of Virology
Verified
Journal Article
Open access
PDF file
YLYang Liu
Yang Liu
PHPengwei Huang
Pengwei Huang
MTMing Tan
Ming Tan
YLYiliu Liu
Yiliu Liu
JBJacek Biesiada
Jacek Biesiada
XJXi Jiang
Xi Jiang
The distal portion of rotavirus (RV) VP4 spike protein (VP8*) is implicated in binding to cellular receptors, thereby facilitating viral attachment and entry. While VP8* of some animal RVs engage sialic acid, human RVs often attach to and enter cells in a sialic acid-independent manner. A recent study demonstrated that the major human RVs (P[4], P[6], and P[8]) recognize human histo-blood group antigens (HBGAs). In this study, we performed a phylogenetic analysis of RVs and showed further variations of RV interaction with HBGAs. On the basis of the VP8* sequences, RVs are grouped into five P genogroups (P[I] to P[V]), of which P[I], P[IV], and P[V] mainly infect animals, P[II] infects humans, and P[III] infects both animals and humans. The sialic acid-dependent RVs (P[1], P[2], P[3], and P[7]) form a subcluster within P[I], while all three major P genotypes of human RVs (P[4], P[6], and P[8]) are clustered in P[II]. We then characterized three human RVs (P[9], P[14], and P[25]) in P[III] and observed a new pattern of binding to the type A antigen which is distinct from that of the P[II] RVs. The binding was demonstrated by hemagglutination and saliva binding assay using recombinant VP8* and native RVs. Homology modeling and mutagenesis study showed that the locations of the carbohydrate binding interfaces are shared with the sialic acid-dependent RVs, although different amino acids are involved. The P[III] VP8* proteins also bind the A antigens of the porcine and bovine mucins, suggesting the A antigen as a possible factor for cross-species transmission of RVs. Our study suggests that HBGAs play an important role in RV infection and evolution.

1 January 2019 in Cellular and Molecular Gastroenterology and Hepatology
Verified
Journal Article
Open access
NSNina G. Steele
Nina G. Steele
JCJayati Chakrabarti
Jayati Chakrabarti
JWJiang Wang
Jiang Wang
JBJacek Biesiada
Jacek Biesiada
LHLoryn Holokai
Loryn Holokai
YZYana Zavros
Yana Zavros
Our goal was to develop an initial study for the proof of concept whereby gastric cancer organoids are used as an approach to predict the tumor response in individual patients. Organoids were derived from resected gastric cancer tumors (huTGOs) or normal stomach tissue collected from sleeve gastrectomies (huFGOs). Organoid cultures were treated with standard-of-care chemotherapeutic drugs corresponding to patient treatment: epirubicin, oxaliplatin, and 5-fluorouracil. Organoid response to chemotherapeutic treatment was correlated with the tumor response in each patient from whom the huTGOs were derived. HuTGOs were orthotopically transplanted into the gastric mucosa of NOD scid gamma mice. Whereas huFGOs exhibited a half maximal inhibitory concentration that was similar among organoid lines, divergent responses and varying half maximal inhibitory concentration values among the huTGO lines were observed in response to chemotherapeutic drugs. HuTGOs that were sensitive to treatment were derived from a patient with a near complete tumor response to chemotherapy. However, organoids resistant to treatment were derived from patients who exhibited no response to chemotherapy. Orthotropic transplantation of organoids resulted in the engraftment and development of human adenocarcinoma. RNA sequencing revealed that huTGOs closely resembled the patient's native tumor tissue and not commonly used gastric cancer cell lines and cell lines derived from the organoid cultures. The treatment of patient-derived organoids alongside patients from whom cultures were derived will ultimately test their usefulness to predict individual therapy response and patient outcome.

27 July 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
Scott M LangevinScott M Langevin
Scott M Langevin
DKDamaris Kuhnell
Damaris Kuhnell
TPTess Parry
Tess Parry
JBJacek Biesiada
Jacek Biesiada
SHShouxiong Huang
Shouxiong Huang
SKSusan Kasper
Susan Kasper
Comprehensive microRNA-sequencing of exosomes derived from head and neck carcinoma cells in vitro reveals common secretion profiles and potential utility as salivary biomarkers Comprehensive microRNA-sequencing of exosomes derived from head and neck carcinoma cells in vitro reveals common secretion profiles and potential utility as salivary biomarkers